Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X024966 | OT |
No other information provided. No additional AEs/PQC reported.; Caller reported VAQTA administered after expiration date.; Information has been received from Business Partner/CRO on 08-Apr-2025. This spontaneous report was received from a/an Other health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with . On an unknown date, the patient started therapy with Hepatitis A Vaccine, Inactivated (lot #X024966, expiration date: 23-Mar-2025) 1 mL administered by Intramuscular route. The patient started therapy with Hepatitis A Vaccine, Inactivated for the treatment of Prophylaxis. On 25-Mar-2025, the patient experienced Caller reported VAQTA administered after expiration date.. On an unknown date, the patient experienced No other information provided. No additional AEs/PQC reported.. At the reporting time, the outcome of Caller reported VAQTA administered after expiration date. and No other information provided. No additional AEs/PQC reported. was unknown. The action taken with Hepatitis A Vaccine, Inactivated was reported as not applicable.